Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Actinium Pharmaceuticals (ATNM) Q2 2024 Earnings
ATNM
26
Apr
Confirmed
Q1 2023
Q2 2023
Q3 2023
Q2 2024
-0.51
-0.34
-0.17
0
Details
Expected EPS
-0.378
Actual EPS
-0.31
Surprise EPS
0.07
Surprise Percent
+17.99%
Description
Actinium Pharmaceuticals (ATNM) has reported earnings of -0.31 per share for Q2 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login